Modular Medical (MODD) Return on Capital Employed (2021 - 2026)
Modular Medical (MODD) posted Return on Capital Employed of 258.23% for Q1 2026, up 9.25% on a QoQ basis from 284.56% in Q4 2025, and down 12388.0% year-over-year from N/an in Q1 2025.
Modular Medical (MODD) Return on Capital Employed (2021 - 2026) Analysis & Trends
Modular Medical's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 258.23% for Q1 2026.
- Quarterly Return on Capital Employed fell 12388.0% year-over-year to 258.23% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 258.23% (down 12388.0% YoY) and the FY2026 annual result came in at 184.84%, down 5790.0% from the prior year.
- Return on Capital Employed was 258.23% for Q1 2026 at Modular Medical, up from 284.56% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 120.92% in Q3 2022 and bottomed at 344.76% in Q1 2022.
- A 5-year average of 198.93% and a median of 197.89% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 51436 bps — and 2023, when it jumped 14687 bps.
- Modular Medical's Return on Capital Employed stood at 152.92% in 2022, then sank by 64 bps to 250.85% in 2023, then rose by 19 bps to 202.59% in 2024, then slumped by 40 bps to 284.56% in 2025, then increased by 9 bps to 258.23% in 2026.
- Business Quant data shows MODD's Return on Capital Employed at 258.23% in Q1 2026, 284.56% in Q4 2025, and 256.76% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 8.38% |
| 10 | Modular Medical | 5.28 Mn | -1.66 Mn | - | -258.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -258.23% |
| Dec 31, 2025 | -284.56% |
| Sep 30, 2025 | -256.76% |
| Jun 30, 2025 | -150.19% |
| Mar 31, 2025 | -134.36% |
| Dec 31, 2024 | -202.59% |
| Sep 30, 2024 | -229.95% |
| Jun 30, 2024 | -169.83% |
| Mar 31, 2024 | -205.07% |
| Dec 31, 2023 | -250.85% |
| Sep 30, 2023 | -138.33% |
| Jun 30, 2023 | -149.60% |
| Mar 31, 2023 | -197.89% |
| Dec 31, 2022 | -152.92% |
| Sep 30, 2022 | -120.92% |
| Jun 30, 2022 | -134.96% |
| Mar 31, 2022 | -344.76% |
| Dec 31, 2021 | 160.75% |
| Sep 30, 2021 | 292.11% |
| Jun 30, 2021 | 379.40% |